Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $65.09.

Several brokerages recently weighed in on TEM. Piper Sandler increased their price objective on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th. Bank of America upped their price target on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. BTIG Research started coverage on Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price target on the stock. Guggenheim upped their price target on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Finally, Morgan Stanley upped their price target on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th.

Insider Transactions at Tempus AI

In other Tempus AI news, CFO James William Rogers sold 23,121 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $63.27, for a total transaction of $1,462,865.67. Following the transaction, the chief financial officer owned 146,001 shares of the company's stock, valued at approximately $9,237,483.27. This trade represents a 13.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Erik Phelps sold 51,317 shares of the firm's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total value of $3,723,561.52. Following the transaction, the executive vice president directly owned 97,779 shares in the company, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 612,522 shares of company stock valued at $41,600,238 over the last ninety days. Company insiders own 27.60% of the company's stock.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently added to or reduced their stakes in TEM. Bank of New York Mellon Corp acquired a new position in Tempus AI in the 4th quarter valued at about $1,615,000. Victory Capital Management Inc. acquired a new position in Tempus AI in the 4th quarter valued at about $216,000. Raymond James Financial Inc. acquired a new position in Tempus AI in the 4th quarter valued at about $3,757,000. Farther Finance Advisors LLC acquired a new position in Tempus AI in the 4th quarter valued at about $34,000. Finally, Axxcess Wealth Management LLC acquired a new position in Tempus AI during the 4th quarter worth approximately $221,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Trading Up 0.5%

Shares of TEM stock opened at $60.98 on Friday. The company's 50-day moving average price is $63.06 and its 200-day moving average price is $55.65. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. The stock has a market cap of $10.56 billion and a price-to-earnings ratio of -7.82. Tempus AI has a twelve month low of $31.36 and a twelve month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. Tempus AI's revenue was up 75.4% compared to the same quarter last year. As a group, equities analysts predict that Tempus AI will post -6.15 earnings per share for the current year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.